1 – 10 of 834
- show: 10
- |
- sort: year (new to old)
- |
- Export
- 2025
- Variant genital gender-affirming surgery : a systematic review (2025) BJU INTERNATIONAL. 135(1). p.40-53
- A comprehensive view of N-glycosylation as clinical biomarker in prostate cancer (2025) BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. 1880(1).
- Multi-stakeholder opinion statement on the care of individuals born with differences of sex development : common ground and opportunities for improvement (2025) HORMONE RESEARCH IN PAEDIATRICS. 98. p.226-242
- 2024
- Staged Phalloplasty by Metoidioplasty First Does Not Appear to Lower Complication Rates (2024) TRANSGENDER HEALTH. 9(5). p.427-435
- Moderate hypofractionated radiotherapy for prostate cancer : 3-year toxicity results of a multicentre randomized phase 3, non-inferiority trial (2024) RADIOTHERAPY AND ONCOLOGY. 193.
- Comparison of different estimated glomerular filtration rates for monitoring of kidney function in oncology patients (2024) CLINICAL KIDNEY JOURNAL. 17(1).
- The Association between Urine N-Glycome and Prognosis after Initial Therapy for Primary Prostate Cancer (2024) BIOMEDICINES. 12(5).
- The association between urine N-glycome and prognosis after initial therapy for primary prostate cancer (2024) BIOMEDICINES. 12(5).
- Radical cystectomy or trimodality therapy for muscle-invasive bladder cancer : a qualitative study exploring patient priorities and counselling needs when making a treatment choice (2024) BMC CANCER. 24(1).
- Multiregion sampling of de novo metastatic prostate cancer reveals complex polyclonality and augments clinical genotyping (2024) NATURE CANCER. 5(1). p.5-7